O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts

International Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 919-922

  Mattern, Jürgen ^a   Eichhorn, Uta ^b   Kaina, Bernd ^b   Volm, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG TUMOR; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; LUNG NON SMALL CELL CANCER; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031594831     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980911)77:6<919::AID-IJC20>3.0.CO;2-V     Document Type: Article

References (26)

1. ANDERSSON, B.S., SADEGHI, T., SICILIANO, M.J., LEGERSKI, R. and MURRAY, D., Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother. Pharmacol., 38, 406-416 (1996).
2. BELANICH, M. and 12 OTHERS, Retrospective. study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res., 56, 783-788 (1996).
3. 6-alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc. nat. Acad. Sci. (Wash.), 82, 2985-2989 (1985).
4. 6-metnylguanine-DNA methyltransferase in ovarian malignancy and its correlation with postoperative response to chemotherapy. Gynecol. Oncol., 52, 172-174 (1994).
5. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Nat. Acad. Sci. (Wash.), 87, 5368-5372 (1990).
6. 6-alkylguanine-DNA alkyltransferase. Proc. Amer. Assoc. Cancer Res., 39, 219 (1998).
7. 6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene (1998). (In press).
8. 6-methylguanine-DNA methyltransferase gene. Cancer Res., 56, 2029-2032 (1996).
9. HILTON, J., Deoxyribonucleic acid crosslinking by 4-hydroperoxy-cyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells. Biochem. Pharmacol., 33, 1867-1872 (1984).
10. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis, 12, 1857-1867 (1991).
11. LANE, D., p53, guardian of the genome. Nature (Lond.), 358, 15-16 (1992).
12. 6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation. Brit. J. Cancer, 66, 331-336 (1992).
13. LIU, L., MARKOWITZ, S. and GERSON, S.L., Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res., 56, 5375-5379 (1996).
14. MAGNI, M., SHAMMAH, S., SCHIRO, R., MELLADO, W., DALLA-FAVERA, R. and GIANNI, A.M., Induction of Cyclophosphamide resistance by aldehyde-dehydrogenase gene transfer. Blood, 87, 1097-1103 (1996).
15. MATTERN, J., BAK, M., HAHN, E.W. and VOLM, M., Human tumor xenografts as model for drug testing. Cancer Metastasis Rev., 7, 263-284 (1988).
16. MATTERN, J., JÄGER, S., SONKA, J., WAYSS, K. and VOLM, M., Growth of human bronchial carcinomas in nude mice. Brit. J. Cancer, 51, 195-200 (1985).
17. MATTERN, J. and VOLM, M., Resistance mechanisms in human lung cancer. Invasion Metastasis, 15, 81-94 (1995).
18. 6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome. Cancer Res., 54, 4524-4531 (1994).
19. NOWAK, K., PECKHAM, M.J. and STEEL, G.G., Variation in response of xenografts of colorectal carcinoma to chemotherapy. Brit. J. Cancer, 37, 576-584 (1978).
20. 6-methylguanine-DNA melhyltransferase activity in breast and brain tumors. Int. J. Cancer, 61, 321-326 (1995)
21. 6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int. J. Cancer, 65, 506-512 (1996).
22. 6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer, 75, 1339-1342 (1995).
23. 6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J. Neurosurg., 70, 573-577 (1989).
24. SMIT, E.F. and POSTMUS, P.E., Chemotherapy of non-small cell lung cancer. In: D.N. Carney (ed.), Lung cancer, pp. 96-113, Arnold, London (1995).
25. VOLM, M., BAK, M., EFFERTH, T., LATHAN, B. and MATTERN, J., Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res., 8, 531-536 (1988).
26. 6-alkylguanine-DNA alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines. Brit. J. Cancer, 66, 840-843 (1992).